A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
FERMENTALG operates in the Biotechnology industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0 | - | 8.1M | 6.7M | - |
| Net Income | -15M | -15M | -10M | -8.1M | -7.9M |
| EPS | $-0.35 | $-0.35 | $-0.25 | $-0.22 | $-0.37 |
| Free Cash Flow | -9.4M | -9.4M | -8.6M | -8.7M | -9.6M |
| ROIC | -47.4% | -25.6% | -19.4% | -18.0% | -24.1% |
| Gross Margin | - | - | 23.8% | 35.1% | - |
| Debt/Equity | 0.00 | 0.46 | 0.24 | 0.19 | 0.53 |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | -13M | -13M | -9.5M | -6.9M | -7.1M |
| Operating Margin | 0.0% | - | -118.1% | -103.7% | - |
| ROE | -45.9% | -39.5% | -20.9% | -20.5% | -33.9% |
| Shares Outstanding | 44M | 44M | 41M | 36M | 21M |
| Metric | 2020 | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | N/A | 6.7M | 8.1M | N/A | 0 |
| Gross Margin | N/A | 35.1% | 23.8% | N/A | N/A |
| R&D | -6.6M | -5.5M | -5.0M | -4.8M | -4.8M |
| SG&A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -7.1M | -6.9M | -9.5M | -13M | -13M |
| Op. Margin | N/A | -103.7% | -118.1% | N/A | 0.0% |
| Net Income | -7.9M | -8.1M | -10M | -15M | -15M |
| Net Margin | N/A | -121.3% | -129.1% | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | -24.1% | -18.0% | -19.4% | -25.6% | -47.4% |
| ROE | -33.9% | -20.5% | -20.9% | -39.5% | -45.9% |
| ROA | -16.4% | -13.5% | -15.7% | -26.7% | -28.2% |
| Cash Flow | |||||
| Op. Cash Flow | -9.6M | -8.7M | -8.6M | -9.4M | -9.4M |
| Free Cash Flow | -9.6M | -8.7M | -8.6M | -9.4M | -9.4M |
| Owner Earnings | -9.8M | -8.8M | -8.9M | -9.6M | -9.6M |
| CapEx | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | N/A | 0 |
| D&A | 0 | 0 | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 54K | 53K | 99K | 24K | 24K |
| Buyback Yield | 0.1% | 0.0% | 0.1% | 0.2% | 0.1% |
| Stock-Based Comp | 160K | 58K | 206K | 181K | 181K |
| Debt Repayment | 1.0M | 6.0M | 553K | 814K | 814K |
| Balance Sheet | |||||
| Net Debt | -1.3M | -20M | -6.0M | 3.4M | -12M |
| Cash & Equiv. | 14M | 31M | 17M | 12M | 12M |
| Long-Term Debt | 12M | 11M | 11M | 16M | 16M |
| Debt/Equity | 0.53 | 0.19 | 0.24 | 0.46 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A |
| Equity | 23M | 55M | 44M | 33M | 33M |
| Total Assets | 48M | 72M | 61M | 55M | 55M |
| Total Liabilities | 25M | 16M | 16M | 21M | 21M |
| Intangibles | N/A | N/A | 15M | 16M | 16M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A |
| Working Capital | 9.6M | 35M | 23M | 19M | 19M |
| Current Assets | 21M | 40M | 28M | 23M | 23M |
| Current Liabilities | 12M | 5.1M | 4.8M | 4.4M | 4.4M |
| Per Share Data | |||||
| EPS | -0.37 | -0.22 | -0.25 | -0.35 | -0.35 |
| Owner EPS | -0.45 | -0.24 | -0.22 | -0.22 | -0.22 |
| Book Value | 1.08 | 1.54 | 1.07 | 0.76 | 0.76 |
| Cash Flow/Share | -0.45 | -0.24 | -0.21 | -0.21 | -0.35 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 21.5M | 36.1M | 41.1M | 44.2M | 44.2M |
| Valuation | |||||
| P/E Ratio | -5.1 | -15.2 | -6.6 | -1.0 | -1.6 |
| P/FCF | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 1.7 | 2.2 | 1.6 | 0.4 | 0.7 |
| Price/Sales | N/A | 18.4 | 8.5 | N/A | N/A |
| FCF Yield | -23.9% | -7.1% | -12.6% | -63.7% | -39.5% |
| Market Cap | 40M | 122M | 69M | 15M | 24M |
| Avg. Price | 1.59 | 3.43 | 2.45 | 0.89 | 0.54 |
| Year-End Price | 1.87 | 3.40 | 1.67 | 0.33 | 0.54 |
FERMENTALG passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 29.4%. Total shareholder yield (buybacks) is 0.1%.
FERMENTALG (ALGAE-PA) has a 5-year average return on invested capital (ROIC) of -21.8%. This is below average and may indicate limited pricing power.
FERMENTALG (ALGAE-PA) has a market capitalization of $24M. It is classified as a small-cap stock.
FERMENTALG (ALGAE-PA) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.10%.
FERMENTALG (ALGAE-PA) operates in the Biotechnology industry, within the Healthcare sector.
FERMENTALG (ALGAE-PA) generated $-9 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
FERMENTALG (ALGAE-PA) has a debt-to-equity ratio of 0.46. This indicates a conservatively financed balance sheet.
FERMENTALG (ALGAE-PA) reported earnings per share (EPS) of $-0.35 in its most recent fiscal year.
FERMENTALG (ALGAE-PA) has a return on equity (ROE) of -39.5%. A negative ROE may indicate losses or negative equity.
FERMENTALG (ALGAE-PA) has a 5-year average gross margin of 29.4%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 4 years of financial data for FERMENTALG (ALGAE-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
FERMENTALG (ALGAE-PA) has a book value per share of $0.76, based on its most recent annual SEC filing.